# Cell-by-Cell Presentation Script Guide

## 📊 **Part 1: demo.ipynb - Foundation Demo (3 minutes)**

### **Cell 0: Overview (Markdown)**
**What to Say:** "This notebook demonstrates a minimal, reproducible workflow for integrating synthetic next-generation sequencing (NGS) variant data and structured clinical data to predict therapy response."

**Key Points:**
- Synthetic data for demonstration
- Interpretable ML models only
- Focus on logic and feasibility

---

### **Cell 1: Load Libraries and Data**
**What to Say:** "We start by loading our essential libraries - pandas for data manipulation and scikit-learn for machine learning. Then we load our synthetic NGS variant data showing 14 mutation records across 10 patients."

**Code Highlights:**
```python
# Load synthetic NGS variant data
ngs_variant_data = pd.read_csv('data/ngs_mock.csv', comment='#')
```

**Key Data Points to Mention:**
- 10 patients (P1-P10)
- Genes: TP53, EGFR, KRAS, ALK, PIK3CA, BRCA1, BRCA2
- Clinical data: age, sex, therapy_response

---

### **Cell 2: Patient-Level Data Alignment**
**What to Say:** "Here's where the magic happens - we pivot the variant data to create gene-level binary features. Each patient gets a 1 if they have a mutation in that gene, 0 otherwise. Then we merge with clinical data."

**Code Highlights:**
```python
# Pivot NGS variant data to gene-level binary encoding
pivot = ngs_variant_data.pivot_table(index='patient_id', columns='gene', values='variant', aggfunc='count', fill_value=0)
pivot = (pivot > 0).astype(int)
```

**Key Insights to Point Out:**
- Patient P1: TP53=1, EGFR=1, responded=1
- Patient P2: KRAS=1, BRCA1=1, responded=0
- Binary encoding ready for ML

---

### **Cell 3: Feature Engineering**
**What to Say:** "We encode categorical features like sex into binary variables and create our final feature matrix with 9 predictors: 7 genes plus age and sex."

**Code Highlights:**
```python
# Encode categorical clinical features
encoded_data['sex_F'] = (encoded_data['sex'] == 'F').astype(int)
encoded_data['sex_M'] = (encoded_data['sex'] == 'M').astype(int)
```

**Feature Matrix to Show:**
- 7 gene features: ALK, BRCA1, BRCA2, EGFR, KRAS, PIK3CA, TP53
- 2 clinical features: age, sex_F, sex_M
- Target: therapy_response

---

### **Cell 4: Model Training**
**What to Say:** "We train two interpretable models: Logistic Regression and Random Forest. On this small synthetic dataset, Logistic Regression achieves 100% accuracy while Random Forest gets 75%."

**Code Highlights:**
```python
# Logistic Regression
logreg = LogisticRegression()
logreg.fit(X_train, y_train)

# Random Forest
rf = RandomForestClassifier(n_estimators=10, random_state=42)
rf.fit(X_train, y_train)
```

**Performance to Mention:**
- Logistic Regression: 100% accuracy (small dataset)
- Random Forest: 75% accuracy

---

### **Cell 5: Model Interpretation**
**What to Say:** "The feature importance tells a biological story. Age is the strongest predictor (0.500), followed by EGFR (0.225) and ALK (0.200) - this aligns with clinical knowledge."

**Key Results to Highlight:**
- Random Forest Feature Importances:
  - age: 0.500
  - EGFR: 0.225  
  - ALK: 0.200
  - sex_F: 0.050
  - PIK3CA: 0.025

**Clinical Insight:** "This makes sense - both patient characteristics and specific mutations drive treatment response."

---

### **Cell 6: Summary (Markdown)**
**What to Say:** "This demonstrates our foundation: a minimal, reproducible workflow that integrates genomic and clinical data to predict therapy response using interpretable models."

---

## 🚀 **Part 2: real_data_enhanced_model.ipynb - Advanced Capabilities (6 minutes)**

### **Cell 0: Overview (Markdown)**
**What to Say:** "Now let's scale this to production with real-world data sources and advanced AI models. This notebook demonstrates a complete end-to-end AI pipeline for precision medicine."

**Workflow Sections to Highlight:**
- Phase 1: Real-World Data Integration
- Phase 2: Advanced AI Model Development  
- Phase 3: Production-Ready Features

---

### **Cell 3: TCGA Genomic Data Access**
**What to Say:** "We connect to The Cancer Genome Atlas via cBioPortal API - the same database used by cancer researchers worldwide. Here we're fetching lung cancer mutation data."

**Code Highlights:**
```python
# Fetch genomic data from TCGA via cBioPortal API
studies_url = f"{base_url}/studies"
mutations_url = f"{base_url}/studies/{study_id}/mutations"
```

**Key Point:** "Real genomic data, not synthetic."

---

### **Cell 5: FHIR Clinical Data Integration**
**What to Say:** "We integrate with FHIR - Fast Healthcare Interoperability Resources. This is the standard API used by electronic health record systems in hospitals."

**Code Highlights:**
```python
class FHIRDataConnector:
    def __init__(self, base_url="http://hapi.fhir.org/baseR4"):
        self.base_url = base_url
```

**Clinical Significance:** "This is how we'd connect to real hospital systems."

---

### **Cell 7: Data Harmonization**
**What to Say:** "The DataHarmonizer class standardizes different data formats. It maps gene symbols, creates genomic features, and standardizes patient IDs using hashing for privacy."

**Key Features to Show:**
- Gene symbol standardization
- Binary feature creation
- Privacy-preserving patient IDs

---

### **Cell 15: Survival Analysis**
**What to Say:** "We use Cox Proportional Hazards model for time-to-event analysis. This tells us not just IF a patient responds, but HOW LONG until progression."

**Key Results to Highlight:**
- Concordance: 0.66 (good discrimination)
- EGFR hazard ratio: 2.36 (increased risk)
- TP53 hazard ratio: 0.38 (protective effect)

**Clinical Impact:** "This helps oncologists plan treatment timelines."

---

### **Cell 16: Advanced Random Forest**
**What to Say:** "Our optimized Random Forest uses 200 trees with balanced class weights to handle the response imbalance."

**Performance Metrics:**
- AUC-ROC: 0.644
- Feature importance ranking

---

### **Cell 22: Patient Clustering**
**What to Say:** "We identify 3 distinct patient subgroups using unsupervised clustering. Each cluster has different response patterns."

**Cluster Analysis to Show:**
- Cluster 0: 75% response rate, mean age 65.6
- Cluster 1: 40% response rate, mean age 49.6  
- Cluster 2: 71% response rate, mean age 56.7

**Clinical Value:** "This helps stratify patients for personalized treatment."

---

### **Cell 24: Model Comparison**
**What to Say:** "We compare multiple models: Neural Network achieves 87.5% AUC, XGBoost gets 62.5%, while traditional models lag behind."

**Results to Highlight:**
- Neural Network: 0.875 AUC
- XGBoost: 0.625 AUC
- Logistic Regression: 0.500 AUC
- Random Forest: 0.500 AUC

---

### **Cell 26: Phase 3 Introduction**
**What to Say:** "Now we enter Phase 3 - Production-Ready Features. This includes cross-validation, SHAP explainability, ensemble stacking, and MLOps deployment."

---

### **Cell 31: Cross-Validation & Hyperparameter Tuning**
**What to Say:** "We use 5-fold stratified cross-validation with GridSearchCV to find optimal hyperparameters. Random Forest achieves 0.644 CV AUC."

**Best Parameters to Show:**
- Random Forest: max_depth=10, n_estimators=100
- XGBoost: learning_rate=0.1, max_depth=6

---

### **SHAP Analysis Section (Cells ~32-35)**
**What to Say:** "SHAP values provide model explainability - crucial for clinical trust. Each patient gets a contribution plot showing how each feature affects their prediction."

**Key SHAP Insights:**
- Feature importance ranking
- Individual patient explanations
- Clinical interpretability

---

### **Ensemble Stacking Section**
**What to Say:** "We combine multiple models using stacking to achieve better performance than any single model."

**Ensemble Benefits:**
- Combines strengths of different algorithms
- Reduces overfitting
- Improves generalization

---

### **Production Pipeline Section**
**What to Say:** "Finally, we wrap this in a production-ready MLOps pipeline with automated model validation, deployment APIs, and monitoring."

**Production Features:**
- Automated hyperparameter tuning
- Model versioning
- Deployment APIs
- Performance monitoring

---

## 🎯 **Presentation Flow Tips**

### **Transitions:**
1. **Demo → Advanced**: "Now let's scale this foundation to production..."
2. **Data → Models**: "With our data integrated, let's see what AI can discover..."
3. **Models → Production**: "These models are powerful, but in healthcare we need production-ready systems..."

### **Technical Credibility Points:**
- Mention specific genes correctly (EGFR, TP53, KRAS)
- Reference clinical significance (EGFR response to Erlotinib)
- Explain SHAP as "clinical explainability"
- Highlight real-world APIs (TCGA, FHIR)

### **Time Management:**
- Demo cells: 2-3 minutes total
- Advanced cells: 5-6 minutes total
- Focus on key insights, not all code

### **Backup Plans:**
- If cells error: "As you can see from the output..."
- If running slow: "Let me show you the results we achieved..."
- If technical issues: Focus on architecture and clinical impact

**You've got this! This shows both technical depth and practical healthcare AI expertise.** 🚀
